Abstract Submission Deadline: October 28, 2025
Pre Early Bird Registration Ends: October 30, 2025

CGT-2026

We cordially invite you to the Global Cell & Gene Therapy Summit-2026, taking place in Boston, MA, from July 6-8, 2026.

Experts speaking @ CGT-SUMMIT 2026

Howard Federoff
Howard Federoff
Chief Medical Officer & Co-Founder

Kenai Therapeutics, FL

Irene Rombel
Irene Rombel
CEO and Co-founder

BioCurie, DE

Jim McNally
Jim McNally
Chief Scientific Officer

Sword Bio, MA

Vladimir Slepushkin
Vladimir Slepushkin
Chief Technology Officer

MedTherapy Biotech, MA

Daniel J.Kota
Daniel J.Kota
Director, Office of Translational Production and Quality

Houston Methodist, TX

Chris Mason
Chris Mason
Professor of Cell & Gene Therapy

University College of London, UK

Amir Hefni
Amir Hefni
Chief Executive Officer

Resolution Therapeutics, UK

John Zhao
John Zhao
Director Process Development

Kytopen, MA

Image
About Event

Welcome to Cell & Gene Therapy Conference Boston, MA

We cordially invite you to the Global Cell & Gene Therapy Summit-2026, taking place in Boston, MA, from July 6-8, 2026. Professionals and researchers are encouraged to participate as speakers’ delegates, sponsors, or exhibitors. This three-day conference aims to bring together a global audience to discuss and exchange ideas on the origins, development, clinical applications, and translational science of cell and gene therapy.
The program features talks, poster presentations, workshops, discussions, and networking events, offering a comprehensive experience designed to engage participants in various interactive formats. Attendees will have the opportunity to learn from experts, showcase their research through posters, gain practical insights in workshops, engage in discussions to share perspectives, and connect with professionals from diverse backgrounds.
This summit serves as a platform to explore the latest breakthroughs and innovations shaping the future of CGT. Join us to contribute, collaborate, and advance the field together. We gladly invite attendees from all around the world to attend The Global Cell & Gene Therapy Summit-2026.
CGT-2026

Key Highlights

Collaboration at the Core
CGT-2026 is dedicated to bridging the gap between academia and industry, facilitating partnerships that accelerate research and development in Cell and Gene Therapy.
Register
Networking Opportunities
Connect with leading researchers, industry experts, and decision-makers to explore collaborations, funding opportunities, and strategic partnerships.
Register
Cutting-edge Research
Gain insights into the latest discoveries and advancements in Cell and Gene Therapy through keynote presentations, panel discussions, and interactive sessions.
Register
Industry Impact
Learn how academic research can translate into practical applications that impact the industry, paving the way for transformative therapies and treatments.
Register
CGT-2026

Media Partner

BioPharma Asia MediaPartner

Biopharma Asia is a leading industry publication that covers the latest trends, research, and innovations in the pharmaceutical, biotechnology, and healthcare sectors. Our mission is to inform and connect industry professionals, driving progress in drug development and patient care. We also promote collaboration and knowledge-sharing across global markets to accelerate scientific breakthroughs and enhance health outcomes.

Scientific Sessions

Key Symposia and Sessions

  • Current Landscape and Future Directions of Cell and Gene Therapy Research
  • Advances in Gene Editing Technologies for Cellular Engineering
  • Stem Cell-Based Therapies: From Bench to Bedside
  • Emerging Gene Therapies for Monogenic Disorders
  • Immunotherapy Approaches: CAR-T Cells and Beyond
  • Cellular Reprogramming and Regenerative Medicine
  • Gene Therapy for Neurodegenerative Diseases: Challenges and Progress
  • Non-Viral Gene Delivery Strategies: Enhancing Safety and Efficiency
  • Clinical Applications of CRISPR-Cas9: Opportunities and Considerations
  • Gene Editing for Hematological Disorders: Promising Results and Ongoing Trials
  • Gene Therapy for Rare Diseases: Navigating Orphan Drug Development
  • Therapeutic Applications of RNA-Based Therapies
  • Gene Therapy Approaches for Cancer Treatment
Apply to Speak

  • CRISPR-Cas9 Advancements: Latest Developments and Applications
  • Beyond CRISPR: Emerging Gene Editing Technologies and Techniques
  • Gene Therapy Target Identification: From Disease Mechanisms to Therapeutic Targets
  • Precision Genome Editing: Strategies for Specific Gene Modifications
  • Editing Non-Coding DNA: Implications for Gene Regulation and Disease Treatment
  • Gene Editing in Stem Cells: Toward Personalized Cell Therapies
  • Gene Delivery Methods: Ensuring Efficient and Safe Editing in Clinical Settings
  • Genetic Disease Models: Translating Findings from Bench to Bedside
  • Immune System Engineering: Enhancing Cell Therapies through Gene Editing
Apply to Speak

  • Manufacturing Strategies for Global Accessibility of Cell and Gene Therapies
  • Process Development and Scale-Up: Challenges and Solutions
  • Quality Control and Assurance in Cell and Gene Therapy Manufacturing
  • Automation and Robotics in Bioprocessing
  • Gene Therapy Vector Production: Advancements and Innovations
  • Ensuring Supply Chain Efficiency for Cell and Gene Therapies
  • Addressing Logistics Challenges in Cell and Gene Therapy Distribution
  • Patient-Specific Manufacturing Approaches: Personalized Medicine at Scale
  • GMP Compliance and Regulatory Considerations in Manufacturing
  • Developing Next-Generation Manufacturing Technologies
  • Contract Manufacturing and Outsourcing Strategies
  • Cost Optimization and Affordability in Cell and Gene Therapy Production
  • Global Collaboration for Streamlining Manufacturing Processes
  • Cell and Gene Therapy Manufacturing Success Stories from Different Regions
Apply to Speak

  • Navigating the Evolving Regulatory Landscape for Cell and Gene Therapies
  • Regulatory Pathways for Accelerated Approvals and Expedited Reviews
  • Addressing Safety and Efficacy Requirements in Regulatory Submissions
  • Risk Management and Pharmacovigilance in Cell and Gene Therapy Trials
  • Reimbursement Models for Advanced Therapies: Challenges and Opportunities
  • Pricing Strategies and Value-Based Pricing for Cell and Gene Therapies
  • Market Entry and Commercialization Planning for Cell and Gene Therapies
  • Market Analysis and Forecasting for Advanced Therapy Products
  • Building Successful Partnerships with Healthcare Providers and Payers
  • Intellectual Property and Patent Strategies in Commercialization
  • Case Studies: From Clinical Trials to Market Success
Apply to Speak
Events Speakers

World Class Speakers
For Conference

Image Image

Harnold Min

Lead Speaker
Image Image

Mike Formalin

Lead Speaker
Image Image

Aronic Kenan

Lead Speaker
Image Image

Joakim Ken

Lead Speaker
Image Image

Mike Formalin

Lead Speaker
Image Image

Joakim Ken

Lead Speaker
Image Image

Harnold Min

Lead Speaker
Image Image

Aronic Kenan

Lead Speaker
Registration Now
Event Schedule

CGT-2026

  • 1st Day
  • 2nd Day
  • 3rd Day
18
August,
2026

Conference About Spicker

  • Apple Upper west side, Brook
  • 10:15 am 07:15 pm
Buy Tickets
18
August,
2026

Envato User Experience Expertise

  • Apple Upper west side, Brook
  • 10:15 am 07:15 pm

Free Event

18
August,
2026

Apple event : inspiring Creative Solution

  • Apple Upper west side, Brook
  • 10:15 am 07:15 pm

Sold Out

18
August,
2026

Conference About Spicker

  • Apple Upper west side, Brook
  • 10:15 am 07:15 pm
Buy Tickets
18
August,
2026

Envato User Experience Expertise

  • Apple Upper west side, Brook
  • 10:15 am 07:15 pm

Free Event

18
August,
2026

Apple event : inspiring Creative Solution

  • Apple Upper west side, Brook
  • 10:15 am 07:15 pm

Sold Out

18
August,
2026

Conference About Spicker

  • Apple Upper west side, Brook
  • 10:15 am 07:15 pm
Buy Tickets
18
August,
2026

Envato User Experience Expertise

  • Apple Upper west side, Brook
  • 10:15 am 07:15 pm

Free Event

18
August,
2026

Apple event : inspiring Creative Solution

  • Apple Upper west side, Brook
  • 10:15 am 07:15 pm

Sold Out

Pre-Early Bird Registration

Register

Academic
$ 899
  • Welcome Coffee
  • Conference Material
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms
Industry
$ 999
  • Welcome Coffee
  • Conference Material
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms
Federal
$ 1049
  • Welcome Coffee
  • Conference Material
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms
Student
$ 599
  • Welcome Coffee
  • Conference Material
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms
CGT-2026

Past Sponsors &
Exhibitors

The CGT Summit has welcomed a diverse range of exhibitors, from global industry leaders to emerging innovators. By showcasing breakthrough technologies, services, and solutions, our past exhibitors have played a key role in advancing the cell and gene therapy field and shaping meaningful collaborations within the community.

CGT-2026

2025 Conference Highlights

Image Image
Image Image
Image Image
Image Image
Image Image
Image Image
Image Image
Image Image
Image Image
Image Image
Image Image
Image Image
Image Image
Image Image
Image Image
Image Image
View More
CGT-2026

Testimonial

Niranjan Kumar

Chief Executive Officer & President, ABSINCGROUP, PA
Indeed the conference went well and every one went back with new learnings and experience sharing. My panel was extremely successful and highly productive as I have received great feedback and complements. I would be 5/5 rating

Cassandra Perkins

Director, Value & Access, Channel, Distribution Consulting; Cell & Gene Therapy Consulting, Syneos Health, NC
It was a true pleasure! I hope to be part of the summit next year! I met amazing people at the Summit.

Arun Upadhyay

CSO & Head of Research & Development, Ocugen, PA
Thank you very much for your kind message and for organizing such a successful event at the 2nd Global Cell and Gene Therapy Summit. I truly appreciate your efforts and the opportunity to participate. The summit was indeed productive and rewarding, offering valuable insights and networking opportunities.

Alessandra De Riva

Head of Process Development and R&D, Advent Bioservices, UK
It was a very good conference, I really enjoyed it.

Vishal Parekh

Business Development Manager, SGS Pharma
It was pleasure attending the event. Very productive !!

Sanjeev Saxena

Chief Commercial Officer, Sepragen Corp., CA
Thank you so much for the arranging the Panel discussion.  It definitely was a very interesting discussion and the questions you asked were very thought-provoking.  It was great to have participated in the panel and learning from other colleagues on the panel. Really enjoyed it. Hope everyone has a safe trip back.

Susan D'Costa

Chief Technical & Commercial Officer, Genezen, MA & IN
It was a pleasure participating in the CGT Summit. I truly enjoyed the insightful discussions and thought-provoking questions. I hope everyone had a productive and inspiring conference experience.

Larry Forman

Founder and CEO, CHO Plus, Inc., CA
I enjoyed participating on the panel with all of you.  I am happy to learn that the audience found it useful.

Arun Srivastava

Professor, University of Florida, FL
It was a pleasure to attend and participate in the meeting, which was extremely well organized.

Mikko Turunen

Chief Scientific Officer, RNatives Inc, Finland
Thank you for the great event, it was a pleasure to attend!

Dr. Jerome Chal

SVP, Head of CMC, Myeloid Therapeutics, MA
The meeting was enjoyable and provided valuable information and networking opportunities.

Dr. Hiroshi Sugimoto

Associate Director, Takeda Development Center Americas Inc., MA
Thank you so much for organizing such a wonderful meeting. I enjoyed meeting new friends and learning about the cutting-edge sciences in cell and gene therapy.

Dr. Anand Srivastava

Chairman & Co-founder, Global Institute of Stem Cell Therapy and Research (GIOSTAR), CA
It was wonderful attending the meeting

Leena Priya Makani

Scientist I (Gene Editing), BioMarin Pharmaceutical Inc., SF
It was indeed an interesting conference. Learnt a lot and made new connections maybe will get chance to work together

Susan Faust

Patent Specialist, Hogan Lovells US LLP, DC
We were happy to provide useful information at the meeting on IP and regulatory issues. I was very impressed by the line-up of speakers and topics. I will certainly recommend this conference to my colleagues.

Dr. Michael Krohn

Co-Chief Executive Officer, Akribion Genomics, a BRAIN Biotech AG Spin-out, Germany
Thank you for the organization and your support on the CGT Summit last week in Boston, It was the first time for me and Akribion to present and take part in a Cell & Gene Therapy conference and I appreciated it!

Trinayan Kashyap

Envoya Inc., MA
The conference was very well organised.

Dr. Jun Yung Woo

Post-doctoral Fellow, National University of Singapore, Singapore
I had a wonderful time learning from everyone present. It was a good experience, Would love to see how I can be a part of this again in the future

Anastasia Kremer

Researcher, University Hospital Tuebingen, Germany
It was a great conference with a lot of interesting speakers!

Jenna Aquino

Biomedical Scientist, University of Central Florida
Thank you for the opportunity to volunteer and attend for the event! I had the chance to meet and network with some people, and I learned a lot. I was able to bring back valuable information to my lab mates and university which was awesome! I really appreciate your time and all the help you have provided to me.

Meena Narayanan

Senior Scientist, Poseida Therapeutics (A Member of Roche group)
Many Many Thanks for inviting me to the 2nd CGT Summit at Orlando. I enjoyed the conference very much and it was a great platform to exchange ideas. I look forward to participating in the CGT summit next time, with more interesting updates from our company.
×
USG Icon USG Conference App

Download Now for Latest updates ⬇️